How to source Singulair generic online in 2026

Quick shot of the tip topic

Montelukast, commonly marketed as Singulair and available in generic form, is a leukotriene receptor antagonist. It reduces inflammation and bronchoconstriction driven by leukotrienes and is prescribed primarily for ongoing control of asthma symptoms and for some forms of allergic rhinitis.

This medicine is intended for daily maintenance therapy and is not a fast-acting rescue medication for sudden asthma attacks. Keep a quick-relief inhaler available and follow your personal asthma action plan; see the section How to take stock montelukast for directions and Systematic Keeping under surveillance and Risk prevention steps for safety checks.

• The active ingredient is montelukast sodium
• Principal uses: long-term asthma control, prevention of exercise-induced bronchoconstriction, and treatment of some allergic symptoms
• Typical presentations: 10 mg film-coated tablet, 5 mg chewable tablet, 4 mg chewable tablet, and 4 mg oral granules

Indicia

Healthcare professionals may recommend montelukast for the following situations:

• Maintenance therapy for asthma in patients who benefit from leukotriene pathway inhibition
• Preventing exercise-induced bronchospasm in susceptible individuals
• Relief of seasonal or perennial allergic rhinitis symptoms when appropriate

Because montelukast carries a boxed warning regarding neuropsychiatric events, clinicians often reserve it for allergic rhinitis when first-line therapies are unsuitable or ineffective. See United States Legal and Safety Information for regulatory context.

Forms and Talents

Montelukast is manufactured in several dosage forms to match patient age and needs:

• 10 mg film-coated tablet for most adults and adolescents
• 5 mg and 4 mg chewable tablets for children
• 4 mg oral granules supplied in single-dose packets; can be swallowed or mixed with soft food

Your prescriber will select the suitable formulation and dose for the patient's age and clinical situation. For instructions on taking the chosen form, refer to How to administer montelukast.

Getting ready prior to beginning

Talk with your clinician about the following items before beginning montelukast:

• Any liver disease history or abnormal liver function tests
• Any current or prior psychiatric, behavioral, or mood disorders
• Known hypersensitivity to montelukast or any inactive ingredients
• If you are pregnant, planning a pregnancy, or breastfeeding
• Whether chewable tablets may contain phenylalanine if the patient has phenylketonuria

If the patient is a child, confirm pediatric dosing, methods for giving granules, and metric monitoring plans with the child’s healthcare provider.

Taking montelukast: a step-by-step guide

• Follow the label and your prescriber’s directions exactly.
• Take the medication at the same time every day to maintain steady drug levels.
• Swallow 10 mg film-coated tablets whole; do not chew, split, or crush them.
• Chewable tablets should be chewed completely before swallowing.
• Oral granules can be placed directly in the mouth or stirred into a spoonful of soft food such as applesauce, then taken immediately after opening the packet.
• Continue daily therapy unless your prescriber instructs you to stop, even when symptoms improve.

In case of suspected overdosed, seek emergency medical care or contact the poison control center. In the United States call 1-800-222-1222 for Poison Help.

For a quick refresher on securing storage ensures that valuables stay safe. and emergency measures, see Practical Storing Tips and Security monitoring and Risk Reduction Measures.

Steps for a Dose was not taken today

If a dose is forgotten, take it as soon as you remember. If the next dose is close, skip the one dose was skipped and resume your regular schedule. Do not try to catch up on a one dose was skipped by taking two doses at once. For routine timing recommendations, return to How to take the right dose this montelukast medication.

Drug Interaction Mechanisms

Some medicines can alter montelukast metabolism or its effects. Notable mutual interaction concerns include:

• Rifampin and rifabutin, which can decrease montelukast plasma concentrations
• Enzyme-inducing antiepileptics such as phenobarbital, carbamazepine, or phenytoin
• Certain antidiabetic agents like rosiglitazone or repaglinide in specific cases
• Cytotoxic agents including paclitaxel in some treatment settings
• Herbal enzyme inducers, for example St. John’s wort

The current list excludes some items. Provide your prescriber and pharmacist with a full list of prescription drugs, over-the-counter medicines, vitamins, and supplements you use. Also discuss alcohol use and tobacco exposure as part of overall asthma care. See Legal and Health and Safety Notes (USA) for related standard precautions.

Daily Resource monitoring and Preventive steps

• Schedule periodic follow-up visits to assess symptom control and adjust treatment as needed.
• Never use montelukast as a substitute for a short-acting rescue inhaler during acute exacerbations.
• Report any new or worsening mood changes, behavioral changes, insomnia, or suicidal thoughts immediately to your clinician.
• Watch for signs of liver trouble such as dark urine, jaundice, persistent nausea, or abdominal pain and notify your prescriber.

For information about the boxed warning and regulatory communications, see Legal and Safety Caveats (USA). If you notice troubling symptoms, do not stop therapy without discussing it with your healthcare provider.

Unwanted reactions

Serious reactions - seek immediate care

• Serious allergic reactions including swelling of the face, lips, tongue, or throat and hives
• Marked worsening of breathing or sudden severe wheeze
• Possible liver injury: yellowing of the skin or eyes, dark urine, persistent abdominal pain
• New or worsening psychiatric or neurologic symptoms including suicidal thinking, agitation, or hallucinations
• Unexplained bleeding, bruises, or painful skin lumps

Mild effects that are commonly encountered

• Head pressure
• Lightheadedness or drowsiness
• Gastrointestinal upset such as stomach pain or nausea
• Upper respiratory symptoms: cough, nasal congestion
• Sleep maintenance problems or vivid dreams

If after effects persist or are bothersome, contact your prescribing clinician for advice. For guidance on keeping track of metrics symptoms, refer to Ongoing Compliance monitoring and Cautionary measures.

Disk the storage of files is essential for data management. Maintenance Guidelines

• Keep montelukast out of the reach and sight of children and pets.
• Store at typical room temperature, between 15 and 30 degrees C (59 to 86 degrees F).
• Protect tablets and granules from moisture and light; keep them in the original packaging when practical.
• Do not use after the expiration date; follow local guidance for safe disposal of unused medicines.

For quick access to administration tips and safety checks, see Proper way to take montelukast and Ongoing Remote monitoring and Preventive steps.

Different tracks and Comparison

Choice of therapy depends on diagnosis, severity, patient preference, and prior response. Optional solutions to montelukast include:

• Zafirlukast (Accolate) - another leukotriene receptor blocker, usually given twice daily and often taken on an empty stomach; generic versions may be less expensive.
• Zileuton (Zyflo) - a 5-lipoxygenase inhibitor that reduces production of leukotrienes; requires periodic liver function system monitoring.
• Inhaled corticosteroids such as fluticasone or budesonide for daily control of asthma symptoms.
• Combination inhalers that include an inhaled corticosteroid plus a long-acting beta agonist for more persistent asthma.
• For allergic rhinitis: oral antihistamines (cetirizine, loratadine) and intranasal corticosteroids (fluticasone, triamcinolone) are commonly used and often available over the counter.

These treatments vary in cost, ongoing monitoring needs, dosing frequency, and adverse effect profiles. Discuss options with your clinician to select the best fit. See Price Guide (USD) for approximate retail cost comparisons.

Prices expressed in United States dollars

The following are approximate cash cost bands in the United States. Actual out-of-pocket cost will vary with pharmacy, location, insurance coverage, discounts, and whether you select brand or generic.

• Generic montelukast 10 mg, 30 tablets: around USD 5 to 30
• Generic chewable montelukast 4 mg or 5 mg, 30 tablets: around USD 10 to 40
• Brand-name Singulair, 30-day supply: commonly USD 200 to 350 or more without insurance
• Zafirlukast (generic): roughly USD 15 to 40 per month
• Zileuton (brand): typically higher, approximately USD 200 to 400 per month retail
• Inhaled corticosteroid inhalers: wide range, roughly USD 30 to 350+ per inhaler depending on product

For exact fixed pricing check local pharmacy quotes, discount programs, manufacturer coupons, or your insurance formulary and copay information disclosed.

Legal and Basic protective safety steps (USA)

• Prescription status: Montelukast is available only by prescription in the United States; a licensed prescriber must authorize it.
• FDA boxed warning: The FDA has added a boxed warning for serious neuropsychiatric events; patients should receive counseling and a Medication Guide each time the drug is dispensed.
• Use in allergic rhinitis: Due to safety considerations, montelukast is commonly reserved for patients who do not respond to or cannot tolerate different treatments.
• Telemedicine: Many states allow telehealth visits for obtaining a prescription, subject to applicable practice regulations.
• Importation: Importing prescription medications from outside the United States may be restricted and could present safety risks; verify legal and safety implications before attempting.
• Do not share prescription records. Follow the prescriber for continuous monitoring, follow-up, and safe use.

If you have doubts about legal issues, telemedicine prescribing, or importing medicines, consult a licensed healthcare professional or pharmacist for navigating help.

Frequently Asked Help Questions

Can I take montelukast with food? Yes. Montelukast may be taken with or without food. See Montelukast dosing and administration details can be found for more relevant information.

What if my symptoms do not improve? Contact your prescriber to reassess your therapycheck this, please. inhaler technique, and identify triggers. See Surveillance and Risk Reduction Measures for follow-up personal mentorship.

How should montelukast be stored? Store at room temperature in the original container and keep out of the reach of children. See Storage space Solutions and Recommendations.

Where can I find more detailed safety information and guidelines? Delve into the Medication Guide provided at dispensing and consult your prescriber or pharmacist. The FDA website also lists safety communications; see Legal and Safety Caveats (USA).